The finalists for the Citeline Japan Awards 2024 have now been announced following consideration by our independent panel of expert judges, selected for their industry knowledge and impartiality.
Full details of the shortlisted companies, organizations and individuals may be viewed here under the individual Awards categories.
The annual awards ceremony – which returns to Tokyo in this its third year – celebrates advancements, achievements and excellence across Japan’s biopharma industry and the country's integral role in the global life sciences and healthcare market. The event will take place at the Palace Hotel in Marunouchi on Tuesday, 22 October.
The 2024 categories cover the pharma and biotech spectrum, including Best New Drug, Biotech Company of the Year and Best CRO and Financing Deal of the Year. Individuals will also be honored in the Executive of the Year and Lifetime Achievement Award. (The latter, along with Pharma Company of the Year, is chosen by senior Citeline editors).
“We extend our congratulations to all those on this year's finalist list – it is a very strong field and there are some outstanding entries. I’d also like to take this opportunity to thank our panel of esteemed judges for volunteering their time and expertise,” said Ian Haydock, Editor-In-Chief, APAC. “We look forward to celebrating the success of the pharma, biotech and global life sciences industries in Tokyo later this month.”
The Citeline Japan Awards 2024 are supported by sponsors ICON and Syneos Health. To book a table for the evening, visit here.
All further details on the Awards are available on the dedicated English website or Japanese website.
We look forward to seeing you at the event in Tokyo!
